BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30232318)

  • 1. Lactic Acidosis and Thrombocytopenia Associated with Linezolid Therapy: A Case Report.
    Xiao B; Deng P; Jin H; Wang H; Cao Y
    Am J Case Rep; 2018 Sep; 19():1117-1120. PubMed ID: 30232318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of lactic acidosis induced by linezolid and vancomycin therapy using cohort and case-control studies of incidence and associated risk factors.
    Mori N; Kamimura Y; Kimura Y; Hirose S; Aoki Y; Bito S
    Eur J Clin Pharmacol; 2018 Apr; 74(4):405-411. PubMed ID: 29222713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk factors of linezolid-induced lactic acidosis: A case report and review.
    Mao Y; Dai D; Jin H; Wang Y
    Medicine (Baltimore); 2018 Sep; 97(36):e12114. PubMed ID: 30200095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linezolid and the risk of lactic acidosis: Data mining and analysis of the FDA Adverse Event Reporting System.
    Dai Y; Wang Y; Zeng Y; Zhang C; Zhou Z; Shi D
    J Clin Pharm Ther; 2020 Dec; 45(6):1422-1426. PubMed ID: 32776380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of linezolid clearance on the induction of thrombocytopenia and reduction of hemoglobin.
    Hiraki Y; Tsuji Y; Matsumoto K; Morita K; Kamimura H; Karube Y
    Am J Med Sci; 2011 Dec; 342(6):456-60. PubMed ID: 21681075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and risk factors of linezolid-induced lactic acidosis.
    Im JH; Baek JH; Kwon HY; Lee JS
    Int J Infect Dis; 2015 Feb; 31():47-52. PubMed ID: 25499040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linezolid-Induced Thrombocytopenia Is Caused by Suppression of Platelet Production via Phosphorylation of Myosin Light Chain 2.
    Tajima M; Kato Y; Matsumoto J; Hirosawa I; Suzuki M; Takashio Y; Yamamoto M; Nishi Y; Yamada H
    Biol Pharm Bull; 2016; 39(11):1846-1851. PubMed ID: 27803456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between risk factors and time of onset for thrombocytopenia in Japanese patients receiving linezolid therapy: a retrospective analysis.
    Ichie T; Suzuki D; Yasui K; Takahashi H; Matsuda M; Hayashi H; Sugiura Y; Sugiyama T
    J Clin Pharm Ther; 2015 Jun; 40(3):279-84. PubMed ID: 25732525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early linezolid-associated lactic acidosis in a patient with Child's class C liver cirrhosis and end stage renal disease.
    Cheng CN; Lin SW; Wu CC
    J Infect Chemother; 2018 Oct; 24(10):841-844. PubMed ID: 29503228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombocytopenia and anemia caused by a persistent high linezolid concentration in patients with renal dysfunction.
    Tsuji Y; Hiraki Y; Matsumoto K; Mizoguchi A; Kobayashi T; Sadoh S; Morita K; Kamimura H; Karube Y
    J Infect Chemother; 2011 Feb; 17(1):70-5. PubMed ID: 20582446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Linezolid-induced lactic acidosis - a brief overview with a case report].
    Pazderkovák J; Kotora V; Dlouhý P; Bartoš H
    Klin Mikrobiol Infekc Lek; 2019 Sep; 25(3):92-96. PubMed ID: 31904104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus.
    Wunderink RG; Mendelson MH; Somero MS; Fabian TC; May AK; Bhattacharyya H; Leeper KV; Solomkin JS
    Chest; 2008 Dec; 134(6):1200-1207. PubMed ID: 18719064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linezolid-induced lactic acidosis.
    Ramesh V; Gattu S; Maqsood M; Rao V
    BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38331448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible recurrent profound thrombocytopenia due to linezolid in a patient with multi-drug resistant tuberculosis: A case report.
    Wang MG; Wang D; He JQ
    Medicine (Baltimore); 2018 Aug; 97(34):e11997. PubMed ID: 30142839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactic acidosis associated with standard dose linezolid in a kidney recipient with impaired renal function.
    Chen CC; Liu WT; Lin SH
    Braz J Infect Dis; 2022; 26(1):101701. PubMed ID: 34942159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic simulation for the quantitative risk assessment of linezolid-associated thrombocytopenia.
    Onita T; Ishihara N; Ikebuchi A; Yano T; Nishimura N; Tamaki H; Ikawa K; Morikawa N; Naora K
    J Clin Pharm Ther; 2022 Dec; 47(12):2041-2048. PubMed ID: 35893441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the risk factors of linezolid-related haematological toxicity in Chinese patients.
    Dai Y; Jiang S; Chen X; Han L; Zhang C; Yu X; Zhang X
    J Clin Pharm Ther; 2021 Jun; 46(3):807-813. PubMed ID: 33555057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of mitral MRSA endocarditis using daptomycin].
    Senneville E; Beltrand E; Legout L; Leroy O; Fayad G
    Med Mal Infect; 2008 Dec; 38 Spec No 2():13-5. PubMed ID: 19185204
    [No Abstract]   [Full Text] [Related]  

  • 19. Linezolid versus vancomycin for nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus in the elderly: A retrospective cohort analysis: Effectiveness of linezolid in the elderly.
    Takada H; Hifumi T; Nishimoto N; Kanemura T; Yoshioka H; Okada I; Kiriu N; Inoue J; Koido Y; Kato H
    Am J Emerg Med; 2017 Feb; 35(2):245-248. PubMed ID: 27832976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia.
    Britt NS; Potter EM; Patel N; Steed ME
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.